Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)

Condition:   Type 2 Diabetes Mellitus Interventions:   Drug: INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010);   Drug: INSULIN GLARGINE (HOE901);   Drug: Metformin;   Drug: Insulin Glulisine (HMR1964) Sponsor:   Sanofi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials